Rules 4.7.3 and 4.10.3 ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 1 Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity Resonance Health Limited ABN/ARBN Financial year ended: 96 006 762 492 30 June 2026 ...
Appendix 4G & Corporate Governance Statement
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Resonance Health
- FY26 Full Year Results & Investor Webinar
- FY26 Full Year Results & FY27 Guidance Investor Presentation
- Appendix 4E, Full Year Statutory Accounts & Annual Report
- FY26 Full Year Results Webinar
- Cessation of Quarterly Reporting
Later from Resonance Health
- Global Strategic Alliance & MSA with Image Analysis Group
- Change in Substantial Holding
- AGM Date & Director Nomination Closing Date
- Liver Fibrosis Device - Clinical Trial Results - Webinar
- Notice of Annual General Meeting/Proxy Form
Follow Resonance Health into a list and get an email when it puts out news.
Follow Resonance Health